Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

NCT01260506 is registered in ClinicalTrials.gov with Vascular Biogenics Ltd. operating as VBL Therapeutics as lead sponsor.

NCT NCT01260506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01260506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
Lead sponsor
Vascular Biogenics Ltd. operating as VBL Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2010
Completion date
December 20, 2018
Enrollment
75 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme